The present invention relates to certain purine nucleoside analogues containing a carbocyclic ring in place of the sugar residue, salts, esters and pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical formulations containing them and to the use of such compounds in therapy, particularly the treatment or prophylaxis of certain vital infections.
本发明涉及一些
嘌呤核苷类似物,其中含有一个
碳环代替糖残基,其盐,
酯和药学上可接受的衍
生物,它们的制备过程,含有它们的制药配方以及这些化合物在治疗中的应用,特别是在治疗或预防某些重要感染方面的应用。